Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
21 Cards in this Set
- Front
- Back
|
Antibiotic
|
Having or pertaining to the ability to destroy or interfere with the development of a living organism. the term is used most commonly to refer to antibacterial drugs
|
|
|
Antibiotic Therapy
|
empiric therapy
prophylactic antibiotic therapy therapeutic subtherapeutic superinfection |
|
|
Antibiotic categories
|
sulfonamides
penicillins cephalosporins carbapenems monobactams aminoglycosides fluoroquinolens |
|
|
Empiric Therapy
|
administration of antibiotics based on the practitioner's judgment of the pathogens most likely to be causing an apparent infection; it involves the presumptive treatment of an infection to avoid treatment delay before specific culture information has been obtained
|
|
|
Prophylactic Antibiotic Therapy
|
antibiotics taken before anticipated exposure to an infectious organism in an effort to prevent the development of infection
|
|
|
Subtherapeutic
|
referring to antibiotic treatment that is ineffective in treating a given infection. possible causes include inappropriate drug therapy, insufficient drug dosing, or bacterial drug resistance
|
|
|
Superinfection
|
1. an infection occurring during antimicrobial treatment for another infection, resulting from overgrowth of an organism not susceptible to the antibiotic used
2. a secondary microbial infection that occurs in addition to an earlier primary infection, often due to weakening of the patient's immune system function by the first infection |
|
|
Hyperlipidemias
|
abnormal amount of lipoproteins or lipids in the blood
|
|
|
Cholesterol and Coronary Heart Disease
|
as blood cholesterol levels increase, the incidence of death and disability related to CHD also increases.
two pronged treatment: 1. primary: prevention of cardiac events with risk factors 2. secondary: prevention of subsequent cardiac events in individuals who have previously suffered a cardiac event |
|
|
Autonomy
|
self determination and the ability to act on one's own; related nursing actions include promoting a patient's decisions or making a decision when a patient is posing harm to himself or herself
|
|
|
beneficence
|
the ethical principle of doing or actively promoting good; related nursing actions include determining how the patient is best served
|
|
|
confidentiality
|
the duty to respect privileged information about a patient; related nursing actions include not talking about a patient in public or outside the context of the health care setting
|
|
|
justice
|
the ethical principle of being fair or equal in one's actions; related nursing actions include ensuring fairness in distributing resources for the care of patients and determining when to treat
|
|
|
nonmaleficence
|
the duty to do no harm to a patient; related nursing actions include avoiding doing any deliberate harm while rendering nursing care
|
|
|
veracity
|
the duty to tell the truth; related nursing actions include telling the truth with regard to placebos, investigational new drugs, and informed consent
|
|
|
Dietary Supplement
|
a product taken by mouth that contains an ingredient intended to supplement the diet, including vitamins, minerals, herbs or other botanicals, amino acids, and substances such as enzymes, organ tissues, glandular preparations, metabolites, extracts and concentrates
|
|
|
Herbal medicine
|
the practice of using herbs to heal
|
|
|
herbs
|
herbaceous plants as well as the bark, roots, leaves, seeds, flowers, and fruit of trees, shrubs, and woody vines, and extracts of these plants and materials that are valued for their savory, aromatic, or medicinal qualities
|
|
|
Over-the-counter drugs
|
medications that are legally available without a prescription
|
|
|
Antilipemics
|
drugs used to lower lipid levels
Antilipemic drugs are used as an adjunct to diet therapy Drug choice based on the specific lipid profile of the patient |
|
|
Coronary heart disease
|
The risk of CHD in patients with cholesterol levels of 300 mg/dL is three to four times greater than that in patients with levels less than 200 mg/dL
|
